{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:29:48Z","timestamp":1775561388910,"version":"3.50.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,6,30]],"date-time":"2004-06-30T00:00:00Z","timestamp":1088553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s00296-004-0454-0","type":"journal-article","created":{"date-parts":[[2004,6,29]],"date-time":"2004-06-29T08:00:34Z","timestamp":1088496034000},"page":"189-197","source":"Crossref","is-referenced-by-count":26,"title":["Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol"],"prefix":"10.1007","volume":"24","author":[{"given":"Johann D.","family":"Ringe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,30]]},"reference":[{"key":"454_CR1","first-page":"407","volume":"1","author":"Mellanby","year":"1919","unstructured":"Mellanby E (1919) An experimental investigation of rickets. Lancet 1:407\u2013411","journal-title":"Lancet"},{"key":"454_CR2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0028-1137830","volume":"45","author":"Huldschinsky","year":"1919","unstructured":"Huldschinsky K (1919) Heilung von Rachitis durch k\u00fcnstliche H\u00f6hensonne. Dtsch Med Wschr 45:712\u2013717","journal-title":"Dtsch Med Wschr"},{"key":"454_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0021-9258(18)85783-0","volume":"53","author":"McCollum","year":"1922","unstructured":"McCollum EV, Simmonds N, Becker JE, Shipley PG (1922) Studies on experimental rickets. XXI: an experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 53:293\u2013296","journal-title":"J Biol Chem"},{"key":"454_CR4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jlac.19284650108","volume":"465","author":"Windaus","year":"1928","unstructured":"Windaus A, Linsert O (1928) Vitamin D. Justus Liebigs Ann Chem 465:148\u2013155","journal-title":"Justus Liebigs Ann Chem"},{"key":"454_CR5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archinte.1978.03630300004002","volume":"138","author":"De","year":"1978","unstructured":"De Luca H (1978) Vitamin D metabolism and function. Arch Intern Med 138:836\u2013847","journal-title":"Arch Intern Med"},{"key":"454_CR6","first-page":"1083","volume":"2","author":"De","year":"1988","unstructured":"De Luca H (1988) The vitamin D story: a collaborative effort of basic science and clinical medicine. Fed Proc Am Soc Exp Biol 2:1083\u20131086","journal-title":"Fed Proc Am Soc Exp Biol"},{"key":"454_CR7","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"Slatoplosky","year":"1984","unstructured":"Slatoplosky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136\u20132143","journal-title":"J Clin Invest"},{"key":"454_CR8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","volume":"310","author":"Hamdy","year":"1995","unstructured":"Hamdy NAT, Kanis JA, Beneton MNC, Brown CB, Juttmann JR, Jordans JGM, Josse S, Meyrier A, Llins R, Fairey IT (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Br Med J 310:358\u2013363","journal-title":"Br Med J"},{"key":"454_CR9","unstructured":"Sch\u00f6mig M, Lamichhane B, Ritz E (2000) Renal bone disease. In: Hosking D, Ringe JD (eds) Treatment of metabolic bone disease. Dunitz, London"},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0169-6009(90)90040-M","volume":"9","author":"Ogata","year":"1990","unstructured":"Ogata E (1990) Hypoparathyroidism: practice and theoretical background for 1\u03b1-OH-D treatment. Bone Miner 9:229\u2013232","journal-title":"Bone Miner"},{"key":"454_CR11","unstructured":"Cundy T (2000) Hypoparathyroidism. In: Hosking D, Ringe JD (eds) Treatment of metabolic bone disease. Dunitz, London"},{"key":"454_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0169-6009(90)90038-H","volume":"9","author":"Pettifor","year":"1990","unstructured":"Pettifor JM (1990) Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D resistant rickets. Bone Miner 9:199\u2013214","journal-title":"Bone Miner"},{"key":"454_CR13","unstructured":"Davies M (2000) Treatment of osteomalacia. In: Hosking D, Ringe JD (eds)Treatment of metabolic bone disease. Dunitz, London"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0002-9343(92)90682-2","volume":"93","author":"McKenna","year":"1992","unstructured":"McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69\u201377","journal-title":"Am J Med"},{"key":"454_CR15","first-page":"13","volume":"5","author":"Krexner","year":"1996","unstructured":"Krexner E, Resch H, Pietschmann P, Bernecker P, Woloscuk W, Vukovich T, Geyer G, Willvonseder R (1996) Vitamin D status in residents of a long-term-care geriatric hospital in Vienna. Osteologie 5:13\u201318","journal-title":"Osteologie"},{"key":"454_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/geronj\/38.1.19","volume":"38","author":"Chapuy","year":"1983","unstructured":"Chapuy MC, Durr F, Chapuy P (1983) Age-related changes in parathyroid hormone and 25-hydroxycholecalciferol levels. J Gerontol 38:19\u201322","journal-title":"J Gerontol"},{"key":"454_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/46.2.324","volume":"46","author":"Chapuy","year":"1987","unstructured":"Chapuy MC, Chapuy C, Meunier PJ (1987) Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 46:324\u2013328","journal-title":"Am J Clin Nutr"},{"key":"454_CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot ME, DuBoef F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637\u20131642","journal-title":"N Engl J Med"},{"key":"454_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/jc.81.3.1129","volume":"81","author":"Chapuy","year":"1996","unstructured":"Chapuy MC, Schott AM, Garnero P, Hans D, Delmas P, Meunier PJ (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129\u20131133","journal-title":"J Clin Endocrinol Metab"},{"key":"454_CR20","unstructured":"Heinkinheimo R, Siev\u00e4nen R, J\u00e4ntti P, M\u00e4ki-Jokela PL, Rajala S, Vuori I (1996) Vitamin D treatment and bone mineral density in the aged. Maturitas 23 [Suppl]:S77\u2013S80"},{"key":"454_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1056\/NEJM199709043371003","volume":"337","author":"Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65\u00a0years of age and older. N Engl J Med 337:670\u2013676","journal-title":"N Engl J Med"},{"key":"454_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO;2-E","volume":"42","author":"Amin","year":"1999","unstructured":"Amin S, LaValley MP, Simms RW, Felson DT (1999) The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum 42:1740\u20131751","journal-title":"Arthritis Rheum"},{"key":"454_CR23","unstructured":"Normann AW (2001) Vitamin D. In: Bowman B, Russell R (eds) Present knowledge in nutrition. International Life Sciences Institute, Washington DC"},{"key":"454_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1146\/annurev.nu.06.070186.002523","volume":"6","author":"Haussler","year":"1986","unstructured":"Haussler MR (1986) Vitamin D receptors: nature and function. Annu Rev Nutr 6:527\u2013562","journal-title":"Annu Rev Nutr"},{"key":"454_CR25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","volume":"67","author":"Webb","year":"1988","unstructured":"Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in the skin. J Clin Endocrinol Metab 67:373\u2013378","journal-title":"J Clin Endocrinol Metab"},{"key":"454_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jcem-71-2-405","volume":"71","author":"Sherman","year":"1990","unstructured":"Sherman SS, Hollis BW, Tobin JD (1990) Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Clin Endocrinol Metab 71:405\u2013413","journal-title":"J Clin Endocrinol Metab"},{"key":"454_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s002239900702","volume":"65","author":"Lau","year":"1999","unstructured":"Lau KHW, Baylink DJ (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D hormone) therapy. Calcif Tissue Int 65:295\u2013306","journal-title":"Calcif Tissue Int"},{"key":"454_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(79)91076-6","volume":"1","author":"Papopoulos","year":"1979","unstructured":"Papopoulos SG, Fraher LJ, Sandler LM, Clemens TL, Lewin IG, O\u2019Riordan JLH (1979) 1,25-dihydroxycholecalciferol in the pathogenesis of hypercalcemia of sarcoidosis. Lancet 1:627\u2013631","journal-title":"Lancet"},{"key":"454_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s002239900701","volume":"65","author":"Avioli","year":"1999","unstructured":"Avioli LV (1999) Vitamin D and the D hormones, alfacalcidol and calcitriol, as therapeutic agents for osteoporotic populations. Calcif Tissue Int 65:292\u2013294","journal-title":"Calcif Tissue Int"},{"key":"454_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S8756-3282(94)00020-4","volume":"16","author":"Ichikawa","year":"1995","unstructured":"Ichikawa F, Sato K, Nanjo M, Nishi Y, Shinki T, Takahahi N, Suda T (1995) Mouse primary osteoblasts express vitamin D 25-hydroxylase mRNA and convert 1\u03b1,25-dihydroxyvitamin D3. Bone 16:129\u2013135","journal-title":"Bone"},{"key":"454_CR31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1359\/jbmr.2000.15.4.770","volume":"15","author":"Shiraishi","year":"2000","unstructured":"Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama T, Matsumoto T, Ogata E (2000) Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 15:770\u2013779","journal-title":"J Bone Miner Res"},{"key":"454_CR32","unstructured":"Dambacher MA, Schacht E (1996) Osteoporosis and active vitamin D metabolites. The shape of things to come. EULAR, Basel"},{"key":"454_CR33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jbmr.5650020604","volume":"2","author":"Seino","year":"1987","unstructured":"Seino I, Tanaka H, Yamaoka K, Yabucchi H (1987) Circulating 1\u03b1,25-dihydroxyvitamin D3 levels after a single dose of 1\u03b1,25-dihydroxyvitamin D3 or 1\u03b1-hydroxyvitamin D3 in normal men. Bone Miner 2:479\u2013485","journal-title":"Bone Miner"},{"key":"454_CR34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bmj.289.6448.785","volume":"289","author":"Hosking","year":"1984","unstructured":"Hosking DJ, Campbell GA, Kemm JR, Cotton RE, Boyd RV (1984) Safety of treatment for subclinical osteomalacia in the elderly. Br Med J 289:785\u2013787","journal-title":"Br Med J"},{"key":"454_CR35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-124-4-199602150-00003","volume":"124","author":"Lips","year":"1996","unstructured":"Lips P, Graafsmans WC, Ooms ME, Bezemer PD, Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 124:400\u2013406","journal-title":"Ann Intern Med"},{"key":"454_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320\u2013323","journal-title":"JAMA"},{"key":"454_CR37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1210\/er.2001-8002","volume":"23","author":"Papadimitropoulos","year":"2002","unstructured":"Papadimitropoulos E, Wells G, Shea B (2002) Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocrine Reviews 23:560\u2013569","journal-title":"Endocrine Reviews"},{"key":"454_CR38","first-page":"268","volume":"23","author":"Scharla","year":"2003","unstructured":"Scharla SH, Schacht E, Bawey S, Kamilli I, Holle D, Lempert UG (2003) Pleiotropic effects of 1-alfa-hydroxyvitamin D (alfacalcidol) in patients with rheumatoid arthritis. Arthritis Rheum 23:268\u2013274","journal-title":"Arthritis Rheum"},{"key":"454_CR39","first-page":"28","volume":"10","author":"Lau","year":"2001","unstructured":"Lau KHW, Baylink DJ (2001) Treatment of 1,25(OH)2D3 (D-hormone) deficiency\/resistance with D hormone and analogs. Osteologie 10:28\u201339","journal-title":"Osteologie"},{"key":"454_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0003-9993(99)90307-6","volume":"80","author":"Bischoff","year":"1999","unstructured":"Bischoff HA, St\u00e4helin HB, Urscheler N (1999) Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 80:54\u201358","journal-title":"Arch Phys Med Rehabil"},{"key":"454_CR41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1532-5415.1999.tb04581.x","volume":"47","author":"Mowe","year":"1999","unstructured":"Mowe M, Haug E, Bohmer T (1999) Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc 47:220\u2013226","journal-title":"J Am Geriatr Soc"},{"key":"454_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s002230010085","volume":"66","author":"Glerup","year":"2000","unstructured":"Glerup H, Mikkelsen H, Poulsen L, Hass ER, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419\u2013424","journal-title":"Calcif Tissue Int"},{"key":"454_CR43","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1016\/S0021-9258(17)39433-4","volume":"260","author":"Simpson","year":"1985","unstructured":"Simpson RU, Thomas GA, Arnold AJ (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260:8882\u20138891","journal-title":"J Biol Chem"},{"key":"454_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/A:1017535728844","volume":"33","author":"Bischoff","year":"2001","unstructured":"Bischoff HA, Borchers M, Gudat F (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 33:19\u201324","journal-title":"Histochem J"},{"key":"454_CR45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/edrv-7-4-434","volume":"7","author":"Boland","year":"1986","unstructured":"Boland R (1986) Role of vitamin D in skeletal muscle function. Endocrine Reviews 7:434\u2013447","journal-title":"Endocrine Reviews"},{"key":"454_CR46","first-page":"157","volume":"Sci","author":"Sorenson","year":"1979","unstructured":"Sorenson OH, Lund B, Saltin B (1979) Myopathy in bone loss of aging: improvement by treatment with 1-alphahydroxycholecalciferol and calcium. Clin Sci (Colch) 56:157\u2013161","journal-title":"Clin"},{"key":"454_CR47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.2000.15.6.1113","volume":"15","author":"Pfeifer","year":"2000","unstructured":"Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15:1113\u20131118","journal-title":"J Bone Miner Res"},{"key":"454_CR48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1359\/jbmr.2003.18.2.343","volume":"18","author":"Bischoff","year":"2003","unstructured":"Bischoff HA, St\u00e4helin HB, Dick W (2003) Effects of vitamin D and calcium supplementation on falls: a randomised controlled trial. J Bone Miner Res 18:343\u2013351","journal-title":"J Bone Miner Res"},{"key":"454_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0165-2478(91)90108-M","volume":"28","author":"M\u00fcller","year":"1991","unstructured":"M\u00fcller K, Diamant M, Bendtzen K (1991) Inhibition of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol Lett 28:115\u2013120","journal-title":"Immunol Lett"},{"key":"454_CR50","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1096\/fj.01-0433rev","volume":"15","author":"DeLuca","year":"2001","unstructured":"DeLuca HF, Cantorna MT (2001) Vitamin D. Its role and uses in immunology. FASEB J 15:2579\u20132585","journal-title":"FASEB J"},{"key":"454_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","volume":"8","author":"Mathieu","year":"2002","unstructured":"Mathieu C, Adorini L (2002) The coming age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8:174\u2013179","journal-title":"Trends Mol Med"},{"key":"454_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s002239900200","volume":"60","author":"Ringe","year":"1997","unstructured":"Ringe JD (1997) Active vitamin D metabolites in glucocorticoid-induced osteoporosis. Calcif Tissue Int 60:124\u2013127","journal-title":"Calcif Tissue Int"},{"key":"454_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s002239900708","volume":"63","author":"Ringe","year":"1999","unstructured":"Ringe JD, C\u00f6ster A, Meng T, Schacht E, Umbach R (1999) Treatment of glucocorticoid-induced osteoporosis with alfacalcidol\/calcium versus vitamin D\/calcium. Calcif Tissue Int 63:337\u2013340","journal-title":"Calcif Tissue Int"},{"key":"454_CR54","unstructured":"Ringe JD, Faber H (2000) Calcium and vitamin D in the prevention and treatment of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 18 [Suppl\u00a021]:S44\u2013S48"},{"key":"454_CR55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02378983","volume":"10","author":"Hayashi","year":"1992","unstructured":"Hayashi Y, Fujita T, Inoue T (1992) Decrease of vertebral fracture in osteoporosis by administration of 1\u03b1-hydroxy-vitamin D3. JBMM 10:184\u2013188","journal-title":"JBMM"},{"key":"454_CR56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","volume":"54","author":"Orimo","year":"1994","unstructured":"Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S (1994) Effects of 1\u03b1-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370\u2013376","journal-title":"Calcif Tissue Int"},{"key":"454_CR57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.43.211","volume":"43","author":"Shiraki","year":"1996","unstructured":"Shiraki M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2\u00a0years\u2019 treatment of osteoporosis with 1\u03b1-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43:211\u2013220","journal-title":"Endocr J"},{"key":"454_CR58","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.28.4.736","volume":"28","author":"Sato","year":"1997","unstructured":"Sato Y, Maruoka H, Oizumi K (1997) Amelioration of hemiplegia-associated osteopenia more than 4\u00a0years after stroke by 1\u03b1-hydroxyvitamin D3 and calcium supplementation. Stroke 28:736\u2013739","journal-title":"Stroke"},{"key":"454_CR59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00002512-199405040-00006","volume":"5","author":"Dechant","year":"1994","unstructured":"Dechant KL, Goa KL (1994) Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis. Drugs Aging 5:300\u2013317","journal-title":"Drugs Aging"},{"key":"454_CR60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00003086-199403000-00033","volume":"300","author":"Menczel","year":"1994","unstructured":"Menczel J, Foldes J, Steinberg R, Leichter I, Shalita B, Bdolah-Abram T et al (1994) Alfacalcidol (alpha D3)and calcium in osteoporosis. Clin Orthop 300:241\u2013247","journal-title":"Clin Orthop"},{"issue":"[Suppl 1","key":"454_CR61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s003930070040","volume":"59","author":"P Lakatos","year":"2000","unstructured":"Lakatos P, Nagy Z, Kiss L, Horvath C, Takacs I, Foldes J et al (2000) Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Z Rheumatol 59 [Suppl\u00a01]:48\u201352","journal-title":"Z Rheumatol"},{"key":"454_CR62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3181\/00379727-191-42922","volume":"191","author":"Gallagher","year":"1989","unstructured":"Gallagher JC, Riggs BL, Recker RR, Goldgar D (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 191:287\u2013292","journal-title":"Proc Soc Exp Biol Med"},{"key":"454_CR63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-113-9-649","volume":"113","author":"Gallagher","year":"1990","unstructured":"Gallagher JC, Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113:649\u2013655","journal-title":"Ann Intern Med"},{"key":"454_CR64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199202063260601","volume":"326","author":"Tilyard","year":"1992","unstructured":"Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol and calcium. N Engl J Med 326:357\u2013362","journal-title":"N Engl J Med"},{"key":"454_CR65","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","volume":"328","author":"Sambrook","year":"1993","unstructured":"Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N et al (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747\u20131752","journal-title":"N Engl J Med"},{"key":"454_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00296-003-0361-9","volume":"24","author":"Ringe","year":"2004","unstructured":"Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW (2004) Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int 24:63\u201370","journal-title":"Rheumatol Int"},{"key":"454_CR67","doi-asserted-by":"crossref","unstructured":"Richy F, Ethgen O, Bruyere O, Reginster J-Y (2004) Efficacy of alfacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int (published online)","DOI":"10.1007\/s00198-003-1570-5"},{"key":"454_CR68","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1359\/jbmr.2000.15.9.1818","volume":"15","author":"Sambrook","year":"2000","unstructured":"Sambrook P, Henderson NK, Keogh A, Macdonald P, Glanville A, Spratt P (2000) Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Min Res 15:1818\u20131824","journal-title":"J Bone Min Res"},{"key":"454_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s002239900195","volume":"60","author":"Akesson","year":"1997","unstructured":"Akesson K, Lau KHW, Baylink DJ (1997) Rationale for active vitamin D analog therapy in senile osteoporosis. Calcif Tissue Int 60:100\u2013105","journal-title":"Calcif Tissue Int"},{"key":"454_CR70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s001980050131","volume":"9","author":"Tanizawa","year":"1999","unstructured":"Tanizawa T, Imura K, Ishii Y, Nishida S, Takano Y, Mashiba T, Endo N, Takahashi HE (1999) Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: a retrospective study. Osteoporos Int 9:163\u2013170","journal-title":"Osteoporos Int"},{"key":"454_CR71","first-page":"37","volume":"10","author":"Fujita","year":"1992","unstructured":"Fujita T, Fukase M, Shimada T, Yamamoto H (1992) Treatment of established osteoporosis with 1\u03b1-(OH)-vitamin D3 and low dose intermittent Elcalcitonin (eel calcitonin derivative). JBBM 10:37\u201340","journal-title":"JBBM"},{"key":"454_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0378-5122(01)00243-2","volume":"40","author":"Ushiroyama","year":"2001","unstructured":"Ushiroyama T, Ikeda A, Sakai M, Higashiyama T, Ueki M (2001) Effects of combined use of calcitonin and 1\u03b1-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low-dose calcitonin. Maturitas 40:229\u2013238","journal-title":"Maturitas"},{"key":"454_CR73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00044011-199815030-00008","volume":"14","author":"Frediani","year":"1998","unstructured":"Frediani B, Allegri A, Bisohno S, Marcolongo R (1998) Effects of combined treatment with calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis. Two years of continuous treatment. Clin Drug Invest 14:235\u2013244","journal-title":"Clin Drug Invest"},{"key":"454_CR74","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1210\/jc.86.8.3618","volume":"86","author":"Gallagher","year":"2001","unstructured":"Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in prevention of age-related bone loss. J Clin Endocrinol Metab 86:3618\u20133628","journal-title":"J Clin Endocrinol Metab"},{"key":"454_CR75","first-page":"100","volume":"dialogue","author":"Ringe","year":"2001","unstructured":"Ringe JD (2001) Osteoporosis in dialogue: 100 questions\u2014100 answers. Thieme, Stuttgart, pp\u00a079\u201380","journal-title":"Osteoporosis in"},{"key":"454_CR76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1359\/jbmr.2003.18.4.769","volume":"18","author":"Paschalis","year":"2003","unstructured":"Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL (2003) Bone mineral and collagen quality in humeri of ovariectomized Cynomolgus monkeys given rhPTH(1\u201334) for 18\u00a0months. J Bone Miner Res 18:769\u2013775","journal-title":"J Bone Miner Res"},{"key":"454_CR77","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1359\/jbmr.2002.17.4.622","volume":"17","author":"Shibata","year":"2002","unstructured":"Shibata T, Shira-Ishi A, Sato T, Masaki T, Sasaki, A, Masuda Y, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito M, Ito M, Ogata E, Watanabe K, Ikeda K (2002) Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. J Bone Miner Res 17:622\u2013629","journal-title":"J Bone Miner Res"},{"key":"454_CR78","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1210\/en.2003-0502","volume":"144","author":"Endo","year":"2003","unstructured":"Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138\u20135144","journal-title":"Endocrinology"},{"key":"454_CR79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1359\/jbmr.2003.18.11.2043","volume":"18","author":"T Koike","year":"2003","unstructured":"Koike T, Okawa T, Wada M, Kita T, Takaoka K (2003) Effects of a long-term alfacalcidol or calcitonin administration on body sway in Japanese elderly women. J Bone Min Res 18 [Suppl\u00a02]:168","journal-title":"J Bone Min Res"},{"key":"454_CR80","first-page":"334","volume":"72","author":"Gallagher","year":"2003","unstructured":"Gallagher JC, Haynafzki G, Fowler S (2003) Calcitriol therapy reduces falls and fractures in elderly women. Calcif Tissue Int 72:334","journal-title":"Calcif Tissue Int"},{"key":"454_CR81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1532-5415.2004.52060.x","volume":"52","author":"Dukas","year":"2004","unstructured":"Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN, Thalmann B, St\u00e4helin HB (2004) Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500\u00a0mg daily. JAGS 52:230\u2013236","journal-title":"JAGS"},{"key":"454_CR82","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.TP.0000065179.06731.99","volume":"75","author":"Henderson-Briffa","year":"2003","unstructured":"Henderson-Briffa K, Keogh A, Sambrook PN, Eismann JA (2003) Reduction by calcitriol of immunosuppressive therapy requirements in heart transplantation. Transplantation 75:2133\u20132134","journal-title":"Transplantation"},{"key":"454_CR83","doi-asserted-by":"crossref","unstructured":"Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D (2004) Alendronate or calcitriol and prevention of bone loss after cardiac transplantation. N Engl J Med 350 (in press)","DOI":"10.1056\/NEJMoa035617"},{"key":"454_CR84","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"Van","year":"2000","unstructured":"Van Staa, TP, Leufkens HGM, Abenhaim A, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"454_CR85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jnnp.66.1.64","volume":"66","author":"Sato","year":"1999","unstructured":"Sato Y, Manabe S, Kuno H, Oizumi K (1999) Amelioration of osteopenia and hypovitaminosis D by 1\u03b1-hydroxyvitamin D3 in elderly patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 66:64\u201368","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0454-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-004-0454-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0454-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0454-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T19:23:40Z","timestamp":1734463420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-004-0454-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,30]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1007\/s00296-004-0454-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,30]]}}}